Skip to main content

Advertisement

Log in

Prospective study of drug-resistant tuberculosis in a spanish urban population including patients at risk for HIV infection

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

From January 1988 to October 1992, the primary resistance to first-line antituberculous drugs in 501 tuberculous patients was evaluated prospectively. Three-hundred and seventeen patients were HIV-negative and 184 were HIV-positive; these patients had several different clinical forms of tuberculosis. Moreover, the acquired resistance to antituberculous drugs was studied in 295 non-AIDS patients and in 42 AIDS patients with evidence of antecedent tuberculosis treatment. The data indicated that during these five years there was no consistent and clear-cut trend toward greater frequency of primary drug resistance to any of the first-line antituberculous drugs. Primary drug resistance in HIV-positive patients (7.1 %) did not differ significantly (p>0.05) from that found in HIV-negative patients (8.2 %). Among HIV-positive patients, the acquired drug resistance pattern was similar to that detected in HIV-negative patients although the frequency of resistance in the former (69 %) was significantly higher (p<0.01). During the study, resistance to isoniazid was almost constant in the acquired-resistance cases and was frequently associated with resistance to other drugs. Furthermore, the acquired resistance to isoniazid was often of a higher level (1 to 10 mg/l) than the primary resistance (0.2 mg/l), and those strains were usually catalase and peroxidase negative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Centers for Disease Control: National action plan to combat multidrug-resistant tuberculosis. Morbidity and Mortality Weekly Report 1992, 41: 5–47.

    Google Scholar 

  2. Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, Driver CR, Snider DE: Nationwide survey of drug-resistant tuberculosis in the United States. Journal of the American Medical Association 1994, 271: 665–671.

    PubMed  Google Scholar 

  3. Chawla PK, Klapper PJ, Kamholz SL, Pollack AH, Henrich AE: Drug-resistant tuberculosis in an urban population including patients at risk for human immunodeficiency virus infection. American Review of Respiratory Disease 1992, 146: 280–284.

    PubMed  Google Scholar 

  4. Beck-Sagué C, Dooley SW, Hulton MD, Otten J, Breeden A, Crawford JT, Pitchenik AE, Woodley CH, Cauthen G, Jarwis WR: Hospital outbreak of multidrug-resistantMycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. Journal of the American Medical Association 1992, 268: 1280–1286.

    PubMed  Google Scholar 

  5. Busillo Ch P, Lessnau KD, Sanjana V, Soumakis S, Davidson M, Muller MP, Talavera W: Multidrug resistantMycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest 1992, 102: 797–801.

    PubMed  Google Scholar 

  6. Edlin BR, Tokars JI, Griego MH, Crawford JT, Williams JN, Sordillo ME, Ong KR, Kilburn JO, Dooley SW, Castro KG, Jarvis WR, Holmberg SD: An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. The New England Journal of Medicine 1992, 326: 1514–1521.

    PubMed  Google Scholar 

  7. Pearson ML, Jereb JA, Frieden TR, Crawford JT, Davis BJ, Dooley SW, Jarvis WR: Nosocomial transmission of multidrug-resistantMycobacterium tuberculosis. At risk patients and health care workers. Annals of Internal Medicine 1992, 117: 191–196.

    PubMed  Google Scholar 

  8. Fischl MA, Daikos GL, Uttamchandani RB, Poblete RB, Moreno JN, Reyes RR, Boota AM, Thompson LM, Cleary TJ, Oldham SA, Saldana MJ, Lai S: Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multidrug-resistant bacilli. Annals of Internal Medicine 1992, 117: 184–190.

    PubMed  Google Scholar 

  9. Bloom BR, Murray CJL: Tuberculosis: commentary on a reemergent killer. Science 1992, 257: 1055–1064.

    PubMed  Google Scholar 

  10. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW: The emergence of drug-resistant tuberculosis in New York City. The New England Journal of Medicine 1993, 328: 521–526.

    PubMed  Google Scholar 

  11. Centers for Disease Control: Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility. Morbidity and Mortality Weekly Report 1991, 40: 129–131.

    Google Scholar 

  12. Dooley SW, Jarvis WR, Martone WJ, Snider DE: Multidrug-resistant tuberculosis. Annals of Internal Medicine 1992, 117: 257–259.

    PubMed  Google Scholar 

  13. Hinman AR, Hughes JM, Snider DE, Cohen ML: Meeting the challenge of multidrug-resistant tuberculosis: summary of a conference. Morbidity and Mortality Weekly Report 1992, 41: 49–57.

    PubMed  Google Scholar 

  14. Centers for Disease Control: Probable transmission of multidrug-resistant tuberculosis in a correctional facility. Morbidity and Mortality Weekly Report 1993, 42: 48–51.

    Google Scholar 

  15. Ausina V, Matas L, Mirelis B, Coll P, Castella J, Prats G: Estudio de las resistencias bacterianas primarias en enfermos tuberculosos en un hospital general. Medicina Clinica 1984, 82: 741–744.

    PubMed  Google Scholar 

  16. Ausina V, Garcia-Barceló M, Luquín M, Belda F, Fernadez J, Esteban G, Sauret J, Mirelis B, Prats G: Estudio de las resistencias bacterianas primarias e iniciales en enfermos tuberculosos de un hospital general durante 1983–1987. Enfermedades Infecciosas y Microbiología Clínica 1990, 8: 274–277.

    Google Scholar 

  17. Canetti G, Grosset G: Techniques et indications des exames bacteriologiques en tuberculosis. Paris. Editions de la Tourelle 1976, p. 77–115.

    Google Scholar 

  18. Heifets LB: Rapid automated method (Bactec system) in clinical mycobacteriology. Seminars in Respiratory Infections 1986, 1: 242–249.

    PubMed  Google Scholar 

  19. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond ED, Sierra MF, Schoolnik GK: Exogenous reinfection with multidrug-resistantMycobacterium tuberculosis in patients with advanced HIV-infection. The New England Journal of Medicine 1993, 328: 1137–1144.

    PubMed  Google Scholar 

  20. Canetti G, Lelirzin M, Gay P, Thibier R, Kreis B, Grosset J: La résistance primaire dans la tuberculose pulmonaire de l'adult en France (1966–1970). Review de Tuberculose et Pneumologie 1972, 36: 337–356.

    Google Scholar 

  21. Schweiger O, Vandra E: The bacteriologic and clinical significance of the catalase activity ofMycobacterium tuberculosis. American Review Tuberculosis 1958, 78: 735–748.

    Google Scholar 

  22. Jackett PS, Aber VR, Lowrie DB: Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains ofMycobacterium tuberculosis. Journal General Microbiology 1978, 104: 37–45.

    Google Scholar 

  23. Cohn ML, Kovitz C, Oda U, Middlebrook G: Studies on isoniazid and tubercle bacilli. II: The growth requeriments, catalase activities, and pathogenic properties of isoniazid-resistant mutants. American Review Tuberculosis 1954, 70: 641–664.

    Google Scholar 

  24. Oestraicher R, Dressler SH, Russell WF, Grow JB, Middlebrook G: Observations on the pathogenicity of isoniazid-resistant mutants of tubercle bacilli for tuberculosis patients. American Review Tuberculosis 1955, 71: 390–405.

    Google Scholar 

  25. Middlebrook G, Cohn ML: Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 1953, 118: 297–299.

    PubMed  Google Scholar 

  26. Snider DE, Kelly GD, Ganther GM, Thompson NJ, Killburn JO: Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. American Review of Respiratory Disease 1985, 132: 125–132.

    PubMed  Google Scholar 

  27. Zhang Y: Genetic basis of isoniazid resistance ofMycobacterium tuberculosis. Research Microbiology 1993, 144: 143–149.

    Google Scholar 

  28. Zhang Y, Heym B, Allen B, Young D, Cole S: The catalase-peroxidase gene and isoniazid resistance ofMycobacterium tuberculosis. Nature 1992, 358: 591–593.

    PubMed  Google Scholar 

  29. Stoeckle MY, Gruan L, Riegler L, Weitzman I, Kreiswirth B, Kornblum J, Laraque F, Riley LW: Catalase-peroxidase gene sequences in isoniazid-sensitive and isoniazid-resistant strains ofMycobacterium tuberculosis from New York city. Journal of Infectious Diseases 1993, 168: 1063–1065.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ausina, V., Riutort, N., Viñado, B. et al. Prospective study of drug-resistant tuberculosis in a spanish urban population including patients at risk for HIV infection. Eur. J. Clin. Microbiol. Infect. Dis. 14, 105–110 (1995). https://doi.org/10.1007/BF02111867

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111867

Keywords

Navigation